ENJAYMO® (sutimlimab-jome) | Cold Agglutinin Disease Treatment ENJAYMO is the first and only FDA-approved treatment for people with cold agglutinin disease (CAD) to help decrease the need for red blood cell transfusion For U S Residents Only ENJAYMO Patient Solutions ( 1-833-223-2428 )